Skip to main content

Table 2 Scores of included CNRG systematic reviews based on elements of the QUOROM statement.

From: Reporting and methodologic quality of Cochrane Neonatal review group systematic reviews

 

QUOROM statement item *

Yes

No

Partially/

Unclear

1.

Title identified as meta-analysis or SR

0 (0)

61 (100)

 

Abstract

   

2.

Structured format used

61 (100)

0 (0)

 

3.

Objectives stated

37 (61)

2 (3)

22 (36)

4.

Data sources reported

61 (100)

0 (0)

 

5.

Review methods reported

   
 

   Selection criteria

61 (100)

0 (0)

 
 

   Validity assessment

4 (7)

57 (93)

 
 

   Data abstraction

7 (11)

54 (89)

 
 

   Study characteristics

1 (2)

60 (98)

 
 

   Data synthesis

36 (59)

25 (41)

 

6.

Results

   
 

   Characteristics of studies

6 (11)

47 (89)

 
 

   Quantitative findings

45 (85)

8 (15)

 
 

   Subgroup

5 (9)

48 (91)

 

7.

Conclusion

61 (100)

0 (0)

 

8.

Introduction

61 (100)

0 (0)

 

Methods

   

9.

Searching

   
 

   Search Terms

61 (100)

0 (0)

 
 

Sources

   
 

Electronic Databases

61 (100)

0 (0)

 
 

MEDLINE

61 (100)

0 (0)

 
 

EMBASE

32 (52)

29 (48)

 
 

CENTRAL

52 (85)

9 (15)

 
 

CINAHL

26 (43)

35 (57)

 
 

Others

33 (54)

28 (46)

 
 

Online Registry of Studies

9 (15)

52 (85)

 
 

Personal Files

8 (13)

53 (87)

 
 

Citations List

53 (87)

8 (13)

 
 

Hand Search of Journals

21 (34)

40 (66)

 
 

Proceedings

47 (77)

14 (23)

 
 

Authors Contacts

10 (16)

51 (84)

 
 

Experts Contact

26 (43)

35 (57)

 
 

Manufacturers

2 (3)

59 (97)

 
 

Restrictions

   
 

Year

2 (3)

58 (95)

1 (2)

 

Publication Status

5 (8)

21 (35)

35 (57)

 

Language

2 (3)

38 (62)

21 (34)

10.

Selection Criteria

61 (100)

0 (0)

 

11.

Validity Assessment

48 (79)

13 (21)

 

12.

Data Abstraction in Duplicate and Independent

58 (95)

3 (5)

 

13.

Clinical Heterogeneity

8 (13)

53 (87)

 

14.

Quantitative Data Synthesis

   
 

Principal Measure of Effect

52 (85)

9(15)

 
 

Method of Combining Data

40 (66)

21 (34)

 
 

Handling Missing Data

43 (70)

18 (30)

 
 

Statistical Heterogeneity

13 (21)

47 (77)

1 (2)

 

Rationale for Subgroups

7 (11)

45 (74)

9 (15)

 

Assessment of Publication Bias

0 (0)

61 (100)

 

Results

   

15.

Trial flow

0 (0)

61 (100)

 

16.

Study characteristics

53 (100)

0 (0)

 

17.

Quantitative data synthesis

   
 

   Agreement on selection

3 (5)

57 (93)

1 (2)

 

   Agreement on validity

2 (4)

51 (94)

1 (2)

 

   Summary result

50 (94)

1 (2)

2 (4)

 

   Present data needed to calculate effect size

52 (98)

1 (2)

 

18.

Discussion

   
 

Summarize key findings

60 (98)

1 (2)

 
 

   Discuss internal and external validity

32 (53)

5 (8)

24 (39)

 

Discuss potential biases

3 (5)

53 (87)

5 (8)

 

Suggest future research

61 (100)

0 (0)

 
  1. * Numbers (percentages)